BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15716243)

  • 21. Cutaneous involvement as the first manifestation in a case of T-cell prolymphocytic leukaemia.
    Serra A; Estrach MT; Martí R; Villamor N; Rafel M; Montserrat E
    Acta Derm Venereol; 1998 May; 78(3):198-200. PubMed ID: 9602226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sezary cell leukaemia: a distinct T cell disorder or a variant form of T prolymphocytic leukaemia?
    Pawson R; Matutes E; Brito-Babapulle V; Maljaie H; Hedges M; Mercieca J; Dyer M; Catovsky D
    Leukemia; 1997 Jul; 11(7):1009-13. PubMed ID: 9204983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rimming of adipocytes by neoplastic lymphocytes: a histopathologic feature not restricted to subcutaneous T-cell lymphoma.
    Lozzi GP; Massone C; Citarella L; Kerl H; Cerroni L
    Am J Dermatopathol; 2006 Feb; 28(1):9-12. PubMed ID: 16456318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [T-cell prolymphocytic leukemia: potential diagnostic pitfalls].
    Dessart P; Lemaire P; Le Dû K; Sandrini J; Prophette B; Maillard H
    Ann Dermatol Venereol; 2014 Dec; 141(12):777-81. PubMed ID: 25433931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinicomorphological characteristics of Sezary's disease and mycosis fungoides].
    Vinogradova IuE; Giliazitdinova EA; Zamulaeva IA; Zybunova EE; Kaplanskaia IB; Kravchenko SK; Kremenetskaia AM; Lutsenko IN; Samoĭlova RS; Selivanova EN; Sidorova IuV; Shklovskiĭ-Kord NE
    Ter Arkh; 2005; 77(10):61-5. PubMed ID: 16320688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small cell variant of T-cell prolymphocytic leukemia with a gammadelta immunophenotype.
    Toyota S; Nakamura N; Dan K
    Int J Hematol; 2005 Jan; 81(1):66-8. PubMed ID: 15717692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. t(8;13)-positive bilineal lymphomas: report of 6 cases.
    Vega F; Medeiros LJ; Davuluri R; Cromwell CC; Alkan S; Abruzzo LV
    Am J Surg Pathol; 2008 Jan; 32(1):14-20. PubMed ID: 18162765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous infiltration in T-cell prolymphocytic leukaemia.
    Mallett RB; Matutes E; Catovsky D; Maclennan K; Mortimer PS; Holden CA
    Br J Dermatol; 1995 Feb; 132(2):263-6. PubMed ID: 7888364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-cell prolymphocytic leukemia: a single-institution experience.
    Ravandi F; O'Brien S; Jones D; Lerner S; Faderl S; Ferrajoli A; Wierda W; Garcia-Manero G; Thomas D; Koller C; Verstovsek S; Giles F; Cortes J; Herling M; Kantarjian H; Keating M
    Clin Lymphoma Myeloma; 2005 Nov; 6(3):234-9. PubMed ID: 16354329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Transgenic mice expressing MTCP1: an animal model for T-cell prolymphocytic leukemia].
    Chiali-Gritti C
    Ann Pharm Fr; 2000 Jan; 58(1):54-61. PubMed ID: 10669814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.
    Herling M; Patel KA; Teitell MA; Konopleva M; Ravandi F; Kobayashi R; Jones D
    Blood; 2008 Jan; 111(1):328-37. PubMed ID: 17890451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged survival in two cases of T-prolymphocytic leukemias with complex hypodiploid chromosomal abnormalities.
    Yokohama A; Karasawa M; Takada S; Matsushima T; Murakami H; Miyao S; Sato S; Naruse T
    J Med; 2000; 31(3-4):183-94. PubMed ID: 11280450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The protean spectrum of non-Hodgkin lymphomas with prominent involvement of subcutaneous fat.
    Massone C; Lozzi GP; Egberts F; Fink-Puches R; Cota C; Kerl H; Cerroni L
    J Cutan Pathol; 2006 Jun; 33(6):418-25. PubMed ID: 16776717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA; Talpur R; Bassett RL; Duvic M
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Unclassified mature T cell leukemia with cerebriform nuclei].
    Takizawa M; Matsushima T; Yokohama A; Handa H; Tsukamoto N; Karasawa M; Murakami H; Nojima Y
    Rinsho Ketsueki; 2005 Jul; 46(7):486-91. PubMed ID: 16440739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How I treat prolymphocytic leukemia.
    Dearden C
    Blood; 2012 Jul; 120(3):538-51. PubMed ID: 22649104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukemia cutis.
    Cho-Vega JH; Medeiros LJ; Prieto VG; Vega F
    Am J Clin Pathol; 2008 Jan; 129(1):130-42. PubMed ID: 18089498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasculitis in erythema induratum of Bazin: a histopathologic study of 101 biopsy specimens from 86 patients.
    Segura S; Pujol RM; Trindade F; Requena L
    J Am Acad Dermatol; 2008 Nov; 59(5):839-51. PubMed ID: 19119100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diagnosis of Sézary syndrome on peripheral blood by flow cytometry requires the use of multiple markers.
    Klemke CD; Brade J; Weckesser S; Sachse MM; Booken N; Neumaier M; Goerdt S; Nebe TC
    Br J Dermatol; 2008 Sep; 159(4):871-80. PubMed ID: 18652582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.